Dynamics of Intracellular Movement and Nucleocytoplasmic Recycling of the Ligand-Activated Androgen Receptor in Living Cells
The DOI matches its OpenAlex record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
An expression construct containing the cDNA encoding a modified aequorea green fluorescent protein (GFP) ligated to the 5'-end of the rat androgen receptor (AR) cDNA (GFP-AR) was used to study the intracellular dynamics of the receptor movement in living cells. In three different cell lines, ie. PC3, HeLa, and COS1, unliganded GFP-AR was seen mostly in the cytoplasm and rapidly (within 15-60 min) moved to the nuclear compartment after androgen treatment. Upon androgen withdrawal, the labeled AR migrated back to the cytoplasmic compartment and maintained its ability to reenter the nucleus on subsequent exposure to androgen. Under the condition of inhibited protein synthesis by cycloheximide (50 microg/ml), at least four rounds of receptor recycling after androgen treatment and withdrawal were recorded. Two nonandrogenic hormones, 17beta-estradiol and progesterone at higher concentrations (10(-7)/10(-6) M), were able to both transactivate the AR-responsive promoter and translocate the GFP-AR into the nucleus. Similarly, antiandrogenic ligands, cyproterone acetate and casodex, were also capable of translocating the cytoplasmic AR into the nucleus albeit at a slower rate than the androgen 5alpha-dihydrotestosterone (DHT). All AR ligands with transactivation potential, including the mixed agonist/antagonist cyproterone acetate, caused translocation of the GFP-AR into a subnuclear compartment indicated by its punctate intranuclear distribution. However, translocation caused by casodex, a pure antagonist, resulted in a homogeneous nuclear distribution. Subsequent exposure of the casodex-treated cell to DHT rapidly (15-30 min) altered the homogeneous to punctate distribution of the already translocated nuclear AR. When transported into the nucleus either by casodex or by DHT, GFP-AR was resistant to 2 M NaCl extraction, indicating that the homogeneously distributed AR is also associated with the nuclear matrix. Taken together, these results demonstrate that AR requires ligand activation for its nuclear translocation where occupancy by only agonists and partial agonists can direct it to a potentially functional subnuclear location and that one receptor molecule can undertake multiple rounds of hormonal signaling; this indicates that ligand dissociation/inactivation rather than receptor degradation may play a critical role in terminating hormone action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tsien, R. Y. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.509 · Cited by 6,143
CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals
Fornerod, M., Ohno, M., Yoshida, M., & Mattaj, I. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80371-2 · Cited by 2,081
Kudo, N., Matsumori, N., Taoka, H., Fujiwara, D., Schreiner, E. P., Wolff, B., Yoshida, M., & Horinouchi, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9112 · Cited by 1,029
A two-step mechanism for the interaction of estradiol with rat uterus.
Jensen, E. V., Suzuki, T., Kawashima, T., Stumpf, W. E., Jungblut, P. W., & DeSombre, E. R. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.59.2.632 · Cited by 1,015
Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor.
Picard, D., & Yamamoto, K. R. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02654.x · Cited by 970
Nuclear localization of unoccupied oestrogen receptors
Welshons, W. V., Lieberman, M. E., & Gorski, J. (1984) · Nature · doi:10.1038/307747a0 · Cited by 871
Transport of Proteins and RNAs in and out of the Nucleus
Nakielny, S., & Dreyfuss, G. (1999) · Cell · doi:10.1016/s0092-8674(00)81666-9 · Cited by 755
Koivisto, P. A., Kononen, J., Palmberg, C., Tammela, T. L. J., HYYTINEN, E.-R., Isola, J. J., Trapman, J., Cleutjens, K. B. J. M., Noordzij, M. A., Visakorpi, T., et al. (1997) · PubMed · Cited by 728
Evidence for a Role of CRM1 in Signal-Mediated Nuclear Protein Export
Ossareh-Nazari, B., Bachelerie, F., & Dargemont, C. (1997) · Science · doi:10.1126/science.278.5335.141 · Cited by 717
Wolff, B., Sanglier, J.-J., & Wang, Y. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90257-x · Cited by 657
Cited by
Androgen receptor: structure, role in prostate cancer and drug discovery
Tan, M. E., Li, J., Xu, H. E., Melcher, K., & Yong, E.-L. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.18 · Cited by 943
Oyola, M. G., & Handa, R. J. (2017) · Stress · doi:10.1080/10253890.2017.1369523 · Cited by 710
“Transcription of target genes is initiated through activation of the pre-initiation complex (Beato, 1989; Beato & Klug, 2000; Tyagi et al., 2000).”
BackgroundDevelopmental basis of sexually dimorphic digit ratios
Zheng, Z., & Cohn, M. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108312108 · Cited by 661
Gonadal steroid hormones and the hypothalamo–pituitary–adrenal axis
Handa, R. J., & Weiser, M. J. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.11.001 · Cited by 408
“In the unbound state, androgen receptors are found in the cytoplasm of cells (Tyagi et al., 2000), and in neurons they have been described in other cellular locations as well (DonCarlos et al., 2003; DonCarlos et al., 2006; Sarkey et al., 2008).”
BackgroundBouchard, J. J., Otero, J. H., Scott, D. C., Szulc, E., Martin, E. W., Sabri, N., Granata, D., Marzahn, M. R., Lindorff-Larsen, K., Salvatella, X., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.08.027 · Cited by 391
Androgen Receptor Phosphorylation
Gioeli, D., Ficarro, S. B., Kwiek, J. J., Aaronson, D., Hancock, M., Catling, A. D., White, F. M., Christian, R. E., Settlage, R. E., Shabanowitz, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204131200 · Cited by 351
Gaughan, L., Logan, I. R., Cook, S., Neal, D. E., & Robson, C. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203423200 · Cited by 310
Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement
Pratt, W. B., Galigniana, M. D., Harrell, J. M., & DeFranco, D. B. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.02.004 · Cited by 285
Structural basis for the nuclear import of the human androgen receptor
Cutress, M. L., Whitaker, H. C., Mills, I. G., Stewart, M., & Neal, D. E. (2008) · Journal of Cell Science · doi:10.1242/jcs.022103 · Cited by 223
The Origin and Functions of Multiple Human Glucocorticoid Receptor Isoforms
LU, N. Z., & CIDLOWSKI, J. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.008 · Cited by 216
Scarpin, K. M., Graham, J. D., Mote, P. A., & Clarke, C. L. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07009 · Cited by 198
Amazit, L., Le Billan, F., Kolkhof, P., Lamribet, K., Viengchareun, S., Fay, M. R., Khan, J. A., Hillisch, A., Lombès, M., Rafestin-Oblin, M.-E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657957 · Cited by 196
DNA binding domains in diverse nuclear receptors function as nuclear export signals
Black, B. E., Holaska, J. M., Rastinejad, F., & Paschal, B. M. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00537-1 · Cited by 189
Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication
Lee, D. K., & Chang, C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030261 · Cited by 183
Plant-derived 3,3′-Diindolylmethane Is a Strong Androgen Antagonist in Human Prostate Cancer Cells
Le, H. T., Schaldach, C. M., Firestone, G. L., & Bjeldanes, L. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300588200 · Cited by 182
The role of androgen receptor mutations in prostate cancer progression.
Brooke, G., & Bevan, C. (2009) · Current Genomics · doi:10.2174/138920209787581307 · Cited by 181
“The unliganded AR is predominantly cytoplasmic [37, 38] and associated with a large heterocomplex, including chaperone and heat-shock proteins, that holds the receptor in a ligand binding competent state [39] (Fig.”
BackgroundRegulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation
Gaughan, L. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki141 · Cited by 174
Mulholland, D. J., Cheng, H., Reid, K., Rennie, P. S., & Nelson, C. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200135200 · Cited by 172
Liganded Androgen Receptor Interaction with β-Catenin
Pawlowski, J. E., Ertel, J. R., Allen, M. P., Xu, M., Butler, C., Wilson, E. M., & Wierman, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200545200 · Cited by 166
Identification and Characterization of a Ligand-regulated Nuclear Export Signal in Androgen Receptor
Saporita, A. J., Zhang, Q., Navai, N., Dincer, Z., Hahn, J., Cai, X., & Wang, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302460200 · Cited by 167
Contribution of the Androgen Receptor to Prostate Cancer Predisposition and Progression
Buchanan, G., Irvine, R. A., Coetzee, G. A., & Tilley, W. D. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1015531326689 · Cited by 165
Haelens, A., Tanner, T., Denayer, S., Callewaert, L., & Claessens, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1701 · Cited by 153
“This nuclear transport is complete 15 to 60 min after hormone stimulation (50).”
BackgroundLigand-dependent inhibition of β-catenin/TCF signaling by androgen receptor
Chesire, D. R., & Isaacs, W. B. (2002) · Oncogene · doi:10.1038/sj.onc.1206049 · Cited by 151
“Our immunofluorescence (IF) analysis utilized fixed cells and did not exploit the sensitivity benefits of confocal microscopy, perhaps explaining how these results differ from those reported (Tyagi et al., 2000; Tomura et al., 2001) insofar as subnuclear AR localization is concerned.”
BackgroundResultAi, J., Wang, Y., Dar, J. A., Liu, J., Liu, L., Nelson, J. B., & Wang, Z. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0188 · Cited by 126
Kraus, S., Gioeli, D., Vomastek, T., Gordon, V., & Weber, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0596 · Cited by 118
“active import and export mechanisms (14, 41, 42).”
BackgroundCinar, B., Mukhopadhyay, N. K., Meng, G., & Freeman, M. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703310200 · Cited by 92
Androgen receptor immunoreactivity in forebrain axons and dendrites in the rat
DonCarlos, L. L., Garcia-Ovejero, D., Sarkey, S., Garcia-Segura, L. M., & Azcoitia, I. (2003) · Endocrinology · doi:10.1210/en.2002-0105 · Cited by 88
Saporita, A. J., Ai, J., & Wang, Z. (2007) · The Prostate · doi:10.1002/pros.20541 · Cited by 77
Androgen receptor expression in the developing male and female rat visual and prefrontal cortex
Nuñez, J. L., Huppenbauer, C. B., McAbee, M. D., Juraska, J. M., & DonCarlos, L. L. (2003) · Journal of Neurobiology · doi:10.1002/neu.10236 · Cited by 71
“Thus, the treatment was intended to override the possible effects of circulating testosterone on AR detection versus expression (Zhou et al., 1994; Tyagi et al., 2000 ).”
BackgroundUBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability
Tsai, J. M., Aguirre, J. D., Li, Y.-D., Brown, J., Focht, V., Kater, L., Kempf, G., Sandoval, B., Schmitt, S., Rutter, J. C., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.028 · Cited by 68
“50 The hydrophobic cleft of AR has several amino acid differences from other NRs, which preferentially accommodate bulkier FxxLF motifs instead of the classic LxxLL. 51,52 We hypothesized that these sequence differences might also prevent UBR5-mediated degradation and asked whether altering the…”
Kesler, C. T., Gioeli, D., Conaway, M. R., Weber, M. J., & Paschal, B. M. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0240 · Cited by 35
Metadata
- Authors
- Tyagi, R. K., Lavrovsky, Y., Ahn, S., Song, C. S., Chatterjee, B., & Roy, A. K.
- Venue
- Molecular Endocrinology
- Publisher
- Oxford University Press
- Published
- 2000-08-01
- Volume
- 14
- Issue
- 8
- Pages
- 1162-1174
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W2064544547
- Cited by
- 291
- References
- 55
- FWCI
- 17.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.